ARTICLE | Clinical News
Raptiva efalizumab regulatory update
October 6, 2008 7:00 AM UTC
Genentech issued a "Dear Healthcare Professional" letter for Raptiva efalizumab to report a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient being treated for chronic ...